News

Domo Delivers Strong Growth in Q3 Fiscal 2025 Results

Domo Delivers Strong Growth in Q3 Fiscal 2025 Results

Domo Reports Impressive Third Quarter Fiscal 2025 Results

Domo, Inc. (Nasdaq: DOMO) has recently released its financial results for the fiscal third quarter, revealing significant growth and promising outlooks for the future. The company recorded a total revenue of $79.8 million, marking a strong performance driven by a $71.1 million subscription revenue component. The billings also showcased stability, amounting to $73.4 million during this quarter.

Fiscal Third Quarter Highlights

Revenue and Performance Figures

The quarterly results indicate a Subscription Remaining Performance Obligation (RPO) of $354.1 million, reflecting a year-over-year increase of 3%. Impressively, the portion of RPO expected to be recognized beyond a twelve-month timeframe stood at $145.9 million—an increase of 14% from the previous year. However, net cash used in operating activities was $13.7 million, and adjusted free cash flow was reported at negative $13.8 million.

Profit Margins and Losses

From an operational standpoint, the GAAP operating margin was reported at negative 14%. In contrast, the non-GAAP operating margin fared better at 3%. The GAAP net loss reached $18.8 million, translating to a GAAP net loss per share of $0.48. Conversely, the non-GAAP net loss was notably lower at $3.2 million, equating to a non-GAAP net loss per share of $0.08 based on an average of 38.8 million shares outstanding.

CEO Statement on Growth Strategy

Josh James, founder and CEO of Domo, expressed optimism about the company’s growth trajectory, emphasizing the positive impacts of their focus on ecosystem-led growth, innovative consumption-based contracts, and advancing AI technology. James highlighted, "Our initiatives are creating robust momentum, increasing demand for Domo as a cornerstone technology in our customers' data architectures. We are strategically positioned to seize the emerging market opportunities driven by the evolution of data and AI landscapes."

Recent Achievements

Acknowledged Leadership in Analytics

Domo's achievements have not gone unnoticed. It was recognized as a leader in Nucleus Research’s 2024 Embedded Analytics Technology Value Matrix for the fourth consecutive year. Additionally, the company topped the 2024 Dresner Advisory Wisdom of Crowds Analytical Platforms Report for the fourth straight year and was named as an “Overall Leader” in the Small and Midsize Enterprise Business Intelligence Market Study.

Future Guidance

Looking forward, Domo provided guidance for the upcoming fourth quarter and full fiscal year. The revenue for Q4 Fiscal 2025 is anticipated to fall between $77.5 million and $78.5 million. For the full fiscal year, revenue expectations are in the range of $315.5 million to $316.5 million, while the non-GAAP net loss per share is projected to be between $0.60 and $0.64.

Conference Call Details

To discuss these results and their implications further, Domo plans to host a conference call today at 3:00 p.m. MT/5:00 p.m. ET, with a live webcast available on the Domo Investor Relations website, ensuring accessibility to its stakeholders.

About Domo

Domo is dedicated to unlocking the power of data for stakeholders across businesses, enhancing their ability to drive substantial impact through actionable insights. Their cloud-native platform surpasses traditional business intelligence offerings, empowering users with interactive dashboards and applications designed for a seamless data experience. With robust AI capabilities and a secure foundation connecting various systems, Domo accelerates the optimization of expansive processes, fostering a culture of curiosity that bolsters business outcomes.

Frequently Asked Questions

What were Domo's total revenues for the third quarter of fiscal 2025?

Domo reported total revenues of $79.8 million for Q3 of fiscal 2025.

Who is the CEO of Domo, and what was his comment on the recent performance?

Josh James is the CEO of Domo and noted that the company is witnessing increased demand due to their strategic focus on technology and AI.

What is Domo's expected revenue range for Q4 Fiscal 2025?

Domo expects Q4 2025 revenue to be between $77.5 million and $78.5 million.

How does Domo rank in recent industry reports?

Domo was named a leader in the Nucleus Research's Embedded Analytics Technology Value Matrix and topped the Dresner Advisory Wisdom of Crowds report.

What are the non-GAAP net loss per share projections for full fiscal 2025?

The non-GAAP net loss per share is expected to range from $0.60 to $0.64 for the full fiscal year 2025.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 0

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 59

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 428

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 221

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 272

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 86

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 171

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 270

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 291

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 106

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading

Top 5 Most Recently Viewed Articles

WellCare of Kentucky Partners with Owen County for Transit Grant

Updated Category News Views 139

WellCare of Kentucky Collaborates with Owen County for a Transportation Grant Improving transportation access for rural residents is essential to reducing barriers for medical visits and other important commitments. WellCare of Kentucky has announced a significant initiative that reflects this commitment by awarding Owen County Public Transit (OCPT) a grant worth $20,000....

Continue Reading
Domo Delivers Strong Growth in Q3 Fiscal 2025 Results

Updated Category News Views 117

Domo Reports Impressive Third Quarter Fiscal 2025 Results Domo, Inc. (Nasdaq: DOMO) has recently released its financial results for the fiscal third quarter, revealing significant growth and promising outlooks for the future. The company recorded a total revenue of $79.8 million, marking a strong performance driven by a $71.1 million subscription revenue component. The...

Continue Reading
Goodfellow Inc. Announces Q3 Earnings and Dividend Update

Updated Category News Views 73

Goodfellow Inc. Declares Q3 Financial Results and Dividend Goodfellow Inc. (TSX: GDL), a prominent name in the wood manufacturing and distribution sector, has recently shared its financial performance for the third quarter. Reporting net earnings of $5.8 million, or $0.68 per share, the figures show a slight decline from last year when net earnings reached $6.2 million at...

Continue Reading
Engagement and Health Awareness at ¡Vive Tu Vida! Event

Updated Category News Views 176

Engagement and Health Awareness at ¡Vive Tu Vida! Event The Mexican American Opportunity Foundation (MAOF) is set to host a spectacular health and wellness fair known as ¡Vive tu vida! Get Up! Get Moving!, where families will gather to celebrate health and promote physical activity. This much-anticipated event underscores the importance of community involvement in...

Continue Reading
Orca Scan Unveils Innovative Tool for Effortless Barcode Design

Updated Category News Views 105

Revolutionizing Barcode Generation with Orca Scan Creating barcodes has now become more accessible thanks to Orca Scan, a dynamic player in the software industry. The company recently unveiled an innovative barcode label designer aimed at streamlining the barcode creation process for users worldwide. This new tool provides enhanced functionality for businesses seeking...

Continue Reading